To investigate the relationship between the presence of MetS and glycemic variability, further multivariate logistic regression adjusting for common clinical parameters that affect glycemic variability (BMI, daily insulin dosage, HbA1c, FCP, and 2hFCP) indicated that the presence of MetS was a risk factor for glycemic variability in our study participants. The gene discussed is INS; the disease is metabolic syndrome.